Gene for the activating natural killer cell receptor, KIR2DS1, is associated with susceptibility to psoriasis vulgaris

Human Immunology

Volumn 65, Issue 7, 2004, Pages 758-766

  Łuszczek, Wioleta ^a   Mańczak, Maria ^a   Cisło, Maria ^b   Nockowski, Piotr ^b   Wiśniewski, Andrzej ^a   Jasek, Monika ^a   Kuśnierczyk, Piotr ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b UNIVERSITY OF WROC AW   (Poland)

Author keywords

HLA Cw6; KIR; Psoriasis susceptibility

Indexed keywords

CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR KIR2DS1; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; GENE ACTIVATION; GENE FREQUENCY; GENETIC RECOMBINATION; GENETIC SUSCEPTIBILITY; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOGENETICS; INTERMETHOD COMPARISON; ISOMER; MAJOR CLINICAL STUDY; MOLECULAR INTERACTION; PRIORITY JOURNAL; PSORIASIS VULGARIS; STATISTICAL SIGNIFICANCE;

ADULT; AGE OF ONSET; DATA INTERPRETATION, STATISTICAL; DNA; ELECTROPHORESIS, AGAR GEL; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-C ANTIGENS; HUMANS; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; POLAND; POLYMERASE CHAIN REACTION; PSORIASIS; RECEPTORS, IMMUNOLOGIC;

EID: 4043108432     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2004.05.008     Document Type: Article

References (31)

1. A.M. Bowcock, W. Shannon, F. Du, J. Duncan, K. Cao, K. Aftergut, J. Catier, M.A. Fernandez-Vina, A. Menter Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies Hum Mol Genet 10 2001 1793
2. F. Capon, M. Munro, J. Barker, R. Trembath Searching for the major histocompatibility complex psoriasis susceptibility gene J Invest Dermatol 118 2002 745
3. J.T. Elder, R.P. Nair, T. Henseler, S. Jenisch, P. Stuart, N. Chia, E. Christopoulos, J.J. Voorhees The genetics of psoriasis 2001 the odyssey continues Arch Dermatol 137 2001 1447
4. K. Asumalahti, C. Veal, T. Laitinen, S. Suomela, M. Allen, O. Elomaa, M. Moser, R. de Cid, S. Ripatti, I. Vorechovsky, J.A. Marcusson, H. Nakagawa, C. Lazaro, X. Estivill, F. Capon, G. Novelli, U. Saarialho-Kere, J. Barker, R. Trembath, J. Kere The Psoriasis Consortium, coding haplotype analysis supports HCR as the putative susceptibility gene for psoriasis at the MHC PSORS1 locus Hum Mol Genet 11 2002 589
5. E. Mallon, M. Bunce, F. Wojnarowska, K. Welsh HLA-Cw*0602 is a susceptibility factor in type I psoriasis, and evidence Ala-73 is increased in male type I psoriasis J Invest Dermatol 109 1997 183
6. C. Enerback, S. Nilsson, F. Enlund, A. Inerot, L. Samuelsson, J. Wahlstrom, G. Swanbeck, T. Martinsson Stronger association with HLA-Cw6 than with corneodesmosin (S-gene) polymorphisms in Swedish psoriasis patients Arch Derm Res 292 2000 525
7. J.E. Gudjó;nsson, A. Karason, A.A. Antonsdóttir, E.H. Runarsdóttir, J.R. Gulcher, K. Stefansson, H. Valdimarsson HLA-Cw6-positive and HLA-Cw6-negative patients with psoriasis vulgaris have distinct clinical features J Invest Dermatol 118 2002 362
8. C. Enerback, T. Martinsson, A. Inerot, J. Wahlstrom, F. Enlund, M. Yhr, G. Swanbeck Evidence that HLA-Cw6 determines early onset of psoriasis, obtained using sequence-specific primers (PCR-SSP) Acta Derm Venerol (Stockholm) 77 1997 273
9. W. Łuszczek, W. Kubicka, M. Cisło, P. Nockowski, M. Mań;czak, G. Woszczek, E. Baran, P. Kuśnierczyk Strong association of HLA-Cw6 allele with juvenile psoriasis in Polish patients Immunol Lett 85 2002 59
10. R. Biassoni, C. Cantoni, D. Pende, S. Sivori, S. Parolini, M. Vitale, C. Bottino, A. Moretta Human natural killer cell receptors and co-receptors Immunol Rev 181 2001 203
11. M. Carrington, P.J. Norman The KIR gene cluster. Vol. 2003, National Library of Medicine (U.S.), National Center for Biotechnology Information, Bethesda, MD http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=Books
12. K.C. Hsu, S. Chida, D. Geraghty, B. Dupont The killer cell immunoglobulin-like receptor (KIR) genomic region gene order, haplotypes and allelic polymorphism Immunol Rev 190 2002 40
13. K. Natarajan, N. Dimasi, J. Wang, R.A. Mariuzza, D.H. Margulies Structure and function of natural killer cell receptors multiple molecular solutions to self, nonself discrimination Annu Rev Immunol 20 2002 853
14. C. Vilches, P. Parham KIR: diverse, rapidly evolving receptors of innate and adaptive immunity Annu Rev Immunol 20 2002 217
15. S.G.E. Marsh, P. Parham, B. Dupont, D.E. Geraghty, J. Trowsdale, D. Middleton, C. Vilches, M. Carrington, C. Witt, L.A. Guethlein, H. Shilling, C.A. Garcia, K.C. Hsu, H. Wain Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002 Hum Immunol 64 2003 648
16. P.D. Borszcz, M. Peterson, L. Standeven, S. Kirwan, M. Sandusky, A. Shaw, E.O. Long, D. Burshtyn KIR enrichment at the effector-target cell interface is more sensitive than signaling to the strength of ligand binding Eur J Immunol 33 2003 1084
17. N.T. Young, M. Uhrberg KIR expression shapes cytotoxic repertoires a developmental program of survival Trends Immunol 23 2002 71
18. J.H. Yen, B.E. Moore, T. Nakajima, D. Scholl, D.J. Schaid, C.M. Weyand, J.J. Goronzy Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis J Exp Med 193 2001 1159
19. S.A. Miller, D.D. Dykes, H.F. Polesky A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acid Res 16 1988 1215
20. N. Gómez-Lozano, C. Vilches Genotyping of human killer-cell immunoglobulin-like receptor genes by polymerase chain reaction with sequence-specific primers an update Tissue Antigens 59 2002 184
21. K.C. Hsu, X.-R. Liu, A. Selvakumar, E. Mickelson, R.J. O'Reilly, B. Dupont Killer Ig-like receptor haplotype analysis by gene content. Evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets J Immunol 169 2002 5123
22. M.P. Martin, G. Nelson, J.-H. Lee, F. Pellet, X. Gao, J. Wade, M.J. Wilson, J. Trowsdale, D. Gladman, M. Carrington Cutting edge susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles J Immunol 169 2002 2818
23. A. Svejgaard, L.P. Ryder HLA and disease associations detecting the strongest association Tissue Antigens 43 1994 18
24. J. Zemmour, P. Parham Distinctive polymorphism at the HLA-C locus implications for the expression of HLA-C J Exp Med 176 1992 937
25. C.S. Falk, D.J. Schendel HLA-C revisited. Ten years of change Immunol Res 16 1997 203
26. A. Neisig, C.J.M. Melief, J. Neefjes Reduced cell surface expression of HLA-C molecules correlates with restricted peptide binding and stable TAP interaction J Immunol 160 1998 171
27. D.R. Johnson Differential expression of human major histocompatibility class I loci HLA-A, -B, and -C Hum Immunol 61 2000 389
28. + in MLC and expand depending on the lack of ligand for KIR on stimulator cells in IL-2 supplemented MLC Hum Immunol 63 2002 638
29. M.P. Martin, X. Gao, J.-H. Lee, G. Nelson, R. Detels, J.J. Goedert, S. Buchbinder, K. Hoots, D. Vlahov, J. Trowsdale, M. Wilson, S.J. O'Brien, M. Carrington Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS Nat Genet 31 2002 429
30. M. Toneva, V. Lepage, G. Lafay, N. Dulphy, M. Busson, S. Lester, A. Vu-Trien, A. Michaylova, E. Naumova, J. McCluskey, D. Charon Genomic diversity of natural killer cell receptor genes in three populations Tissue Antigens 57 2001 358
31. R. Rajalingam, P. Krausa, H.G. Shilling, J.B. Stein, A. Balamurugan, M.D. McGinnis, N.W. Cheng, N.K. Mehra, P. Parham Distinctive KIR and HLA diversity in a panel of north Indian Hindus Immunogenetics 53 2002 1009